The association between declines in blood lead levels and changes in both systolic and diastolic blood pressure.
Gilead’s Tecartus dropped from list of CAR-Ts with updated boxed warnings
Gilead’s Tecartus has been removed from the FDA’s list of CAR-T therapies that should have a boxed warning on the risks of secondary cancer after